Pro-calcitonin and inflammation in chronic hemodialysis

Pro-calcitonin and inflammation in chronic hemodialysis

Procalcitonin (PCT) has emerged as a marker of infection, a frequent complication in hemodialysis (HD). We analyzed PCT levels in chronic non-acutely infected HD subjects, assessed its correlation with inflammatory and nutritional markers and propose a PCT reference value for non-infected HD patient...

Full description

Saved in:
Bibliographic Details
Published in:Medicina (Buenos Aires) Vol. 73; no. 5; pp. 411 - 416
Main Authors: Trimarchi, Hernán, Dicugno, Mariana, Muryan, Alexis, Lombi, Fernando, Iturbe, Leticia, Raña, María S, Young, Pablo, Nau, Karin, Iriarte, Romina, Pomeranz, Vanesa, Forrester, Mariano, Karl, Alejandra, Alonso, Mirta
Format: Journal Article
Language:English
Published: Argentina 2013
Subjects:
Adult
Age Factors
Aged
Aged, 80 and over
Bacterial Infections - blood
Biomarkers - blood
C-Reactive Protein - analysis
Calcitonin - blood
Calcitonin Gene-Related Peptide
Case-Control Studies
Cross-Sectional Studies
Female
Humans
Kidney Failure, Chronic - therapy
Male
Middle Aged
Nutritional Status
Predictive Value of Tests
Protein Precursors - blood
Reference Values
Renal Dialysis - adverse effects
Sex Factors
Time Factors
Vasculitis - blood
Vasculitis - etiology
hemodialysis
procalcitonin
C-reactive protein
inflammation
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Procalcitonin (PCT) has emerged as a marker of infection, a frequent complication in hemodialysis (HD). We analyzed PCT levels in chronic non-acutely infected HD subjects, assessed its correlation with inflammatory and nutritional markers and propose a PCT reference value for non-infected HD patients. In an observational cross-sectional study, 48 chronic HD patients and 36 controls were analyzed. age, gender, time on HD; diabetes; vascular access, PCT, C-reactive protein (CRP), albumin, malnutrition inflammatory score (MIS), hematocrit, leukocyte count, and body mass index (BMI). Subsequently, control (G1, n = 36, 43%) vs. non-infected patients (G2, n = 48, 57%) groups were compared. In control subjects (G1), age: 54.3 ± 13.7 years, range (r): 30-81; males: 19 (53%); median PCT 0.034 ng/ml (r: 0.02-0.08); median CRP 0.80 mg/ dl (r: 0.36-3.9); p95 PCT level: 0.063 ng/ml. In G2, age: 60.2 ± 15.2 years; males 32 (67%), time on HD: 27.0 ± 24.4; diabetics: 19 (32%); median PCT: 0.26 ng/ml (r: 0.09-0.82); CRP: 1.1 mg/dl (r: 0.5-6.2); p95 PCT level: 0.8 ng/ml. In control subjects, PCT and CRP were significantly lower than in G2: PCT: 0.034 vs. 0.26 ng/ml, p = 0.0001; CRP: 0.8 vs. 1.1 mg/dl, p = 0.0004. PCT-CRP correlation in G2: p = 0.287, p = 0.048. PCT and CRP concentrations are elevated in chronic non-acutely infected HD subjects, independently of infection, diabetes and vascular access. A p95 PCT level of 0.8 ng/ml may be considered as the upper normal reference value in non-acutely infected HD subjects. The PCT cut-off level in HD is yet to be determined in HD.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
ISSN:0025-7680